Project•0 Views
CTAP · GLPI-103 — Regulatory Dossier (Type 2 Diabetes)
July 13, 2026
CTAP · GLPI-103 — the hand-authored reference dossier (GLP-1 / Apelin dual agonist, type 2 diabetes).
CTAP · GLPI-103 — 직접 저술한 기준 도시어 (GLP-1 / 아펠린 이중작용제, 제2형 당뇨).
Part of / 소속: CTAP · Status / 상태: Beta (베타)
Comments (0)
No comments yet. Be the first to say something!